Abstract:Objective To study the pharmacokinetics and relative bioavailability of sustained-release lovastatin capsules in healthy Beagle dogs and to assess the bioequivalence and performance of the sustained release of the capsules. Methods Following a single dose of 40 mg of the sustained-release lovastatin capsules(test preparation) and conventional lovostatin capsules(reference preparation) administered by gastrogavage to each of the 4 dogs in a randomized crossover design,the plasma levels of the active drugs at different time points thereafter were determined with HPLC and the plasma drug concentration-time curves of these preparations were drawn.The pharmacokinetic parameters as well as the relative bioavailability were calculated. Results The Tmax values of the test preparation and reference preparation were(2.167±0.408) and((3.167)±0.408)h;the C_(max) values were(23.960±6.091) and(14.307±4.319) nmol·L~(-1);and the AUC_(0~t) were(118.647±13.369) and(129.065±14.729) nmol·h·L~(1),respectively.Calculated with AUC and compared with the reference preparation,the relative bioavailability of lovastatin in the test preparation was (110.4±9.6)% in average.The results of variance analysis showed that the differences between the test and reference preparations with respect to periods and preparations were not significant(P0.05).The differences between individual subjects,however,were significant.The 90% confidence interval of AUC_(0~t) of the test praparation was 101.3%～119.5% of that of the reference preparation. Conclusion The sustained-release lovastatin capsules and the conventional lovastatin capsules were shown to be bioequivalent in terms of the degree of absorption.

Pharmacokinetics and bioequivalence of Nifedipine Sustained-release Pellets in Bea-gle dogs

Pharmacokinetics and bioequivalence of nicotinic acid sustained-release capsules in beagle dogs

Pharmacokinetics and Bioequivalence of Penciclovir Sustained-release Pellets in Beagle Dog

Pharmacokinetics of M-Nifedipine in Beagle Dogs

Comparison of the Pharmacokinetics Between the Two Injections of Nimodipine in Beagle

Pharmacokinetics and Relative Bioavailability of Sustained-Release Alfzosin Hydrochloride Capsules in Healthy Beagle Dogs

Study on the Bioavailability and Pharmacokinetics of Guaiphenesin Sustained Release Tablets in Beagle Dogs

Determination of MN9201,a M-Nifedipine Analogue,in Beagle Dog by RP-HPLC

Study on Pharmacokinetics Compound Niacin Extended-release Tablets in Beagle Dogs

Relative bioavailability and pharmacokineties of two oral nifedipine sustained-release capsules in Chinese volunteers after single dose administration

In Vitro Release and Pharmacokinetics of Sustained-release Tablets Loaded with Felodipine in Beagle Dogs

Bioequivalence and Pharmacokinetic Characteristics of Lovastatin Sustained Release Tablets in Beagle Dogs

Pharmacokinetics of the Analogs at C3 and C5 of M-Nifedipine in Beagle Dogs

A Pharmacokinetic Study on Carteolol Hydrochloride Matrix Sustained-release Pellets in Beagle Dogs

Plasma concentration of sibutramine hydrochloride in beagle dog assayed by LC-MS and study on its pharmacokinetics

Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs

Effect of N-trimethyl Chitosan on the Pharmacokinetic Parameters of Nifedipine Tablets in Beagle Dogs

Study on pharmacokinetics of sustain-realease tablets of niacin and lovastatin in Beagle dogs

Pharmacokinetics and bioequivalence of deferiprone extended-release tablets in Beagle dogs

Pharmacokinetics of carvedilol floating tablets in Beagle dogs

A Study of the Pharmacokinetics and Bioavailability of Sustained-release Lovastatin Capsules in Dogs